foxo4 dri peptide senolytic 2023 2024 study FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI part 1 #peptide #molecule

Daneshmand, M., Kashefizadeh, M., Soleimani, M., Mirzaei, S

Clinical trials in Alzheimers patients have been largely negative

Chen Y, Guo Q, Zhang M, Song S, Quan T, Zhao T, Li H, Guo L, Jiang T, Wang G

Possible allergic reactions to the ingredients of the preparation Potential disruption of the physiological balance of the immune system Lack of data on long-term safety in humans Possible local irritation or reactions at the injection site Risk of interactions with other medications or immunomodulatory therapies Contraindications The use of Epitalon and thymulin is not recommended in individuals with certain conditions or in specific clinical states, due to the lack of safety studies in these populations